Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease-Reference-Cited by-同舟云学术

Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease

Published:2005 Issue:1 Volume:54 Page:184-191
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Trad Salim,Amoura Zahir,Beigelman Catherine,Haroche Julien,Costedoat Nathalie,Boutin Le Thi Huong Du,Cacoub Patrice,Frances Camille,Wechsler Bertrand,Grenier Philippe,Piette Jean-Charles

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference36 articles.

1. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population

2. Mortality and causes of death in a Swedish series of systemic sclerosis patients

3. Scleroderma renal crisis

4. Pulmonary hypertension in the crest syndrome variant of systemic sclerosis

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary Hypertension in Interstitial Lung Disease;CHEST;2024-05

2. Impact of Systemic Sclerosis-Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival;CHEST;2024-01

3. Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review;RMD Open;2023-11

4. Predictors of Pulmonary Hypertension and Right Ventricular Dysfunction in Patients with Hypersensitivity Pneumonitis;Life;2023-06-08

5. Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis;Arthritis Research & Therapy;2023-05-12